7-Epi 10-desacetyl paclitaxel
CAS : 78454-17-8
Ref. 3D-IE22703
5mg | 286,00 € | ||
10mg | 420,00 € | ||
25mg | 598,00 € | ||
50mg | 854,00 € | ||
100mg | 1.339,00 € |
Informations sur le produit
- 10-Deacetyl-7-epi-taxol10-Deacetyl-7-epitaxol10-Desacetyl-7-epipaclitaxelPaclitaxel related compound B
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- 7-EPI-10-DEACETYL-TAXOL
- Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (2aR,4R,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- 7-Epi-10-deacetyltaxol
- 7-epi-10-Deacetyltaxol
- 2'-epi-3'-epi-10-Deacetyltaxol
- 10-Deacetyl-7-epitaxol
7-Epi 10-desacetyl paclitaxel is a prodrug of paclitaxel. It has a similar mechanism of action to paclitaxel, and is used as a chemotherapeutic agent for the treatment of cancer. 7-Epi 10-desacetyl paclitaxel has shown potent apoptotic activity in cell culture, as well as in animal models. This drug is prepared by high performance liquid chromatography and is used to treat cancer. The drug may also be activated by an enzyme called adenosine diphosphate ribose (ADPR), which forms from ATP during cellular metabolism. 7-Epi 10-desacetyl paclitaxel may also have anticancer effects on cervical cancer cells due to its ability to inhibit the synthesis of DNA and RNA.
Propriétés chimiques
Question d’ordre technique sur : 3D-IE22703 7-Epi 10-desacetyl paclitaxel
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages